In addition, a preclinical study using a murine model of head and neck cancer showed that the suppressive activity of TIM-3 can be reversed by IFN-γ secreted by CD8+ T cells upon PD-1 blockade41. The gene discussed is CD8A; the disease is head and neck cancer.